Women support delayed removal of ovaries
Full article: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.16424
Risk-reducing early removal of fallopian tubes followed by removal of ovaries at a later date was acceptable to women at high risk of ovarian cancer due to an inherited mutation in a recent study. This was especially true for women worried about sexual dysfunction associated with surgical menopause. (12/24/20)
Questions To Ask Your Health Care Provider
- Is risk-reducing removal of the fallopian tubes followed by delayed removal of the ovaries (RRESDO) an option for me?
- What can I expect after RRSO?
- What can I expect after RRESDO?
- How do the benefits of RRESDO compare to the risks?
- How would two surgeries with RRESDO impact my quality of life compared to one surgery with RRSO?
- If I have RRESDO, what type of screening should I consider prior to the second surgery?
- Do I qualify for any research studies on ovarian cancer risk reduction?
- I am experiencing menopause effects from my RRSO. Can you refer me to a menopause expert?
Open Clinical Trials
The following are studies looking at ovarian cancer screening or prevention.
Additional clinical trials for ovarian cancer screening and prevention may be found here.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.